Publications

  1. Kusne YN, Kosiorek HE, Buras MR, Coppola KE, Verona PM, Cook CB, Karlin NJ. Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer. Future Sci OA. 2020 Dec 18; 7 (3):FSO670
    View PubMed
  2. Nafissi NN, Karlin N, Pittelkow MR, Dicaudo DJ, Mangold AR. Panniculitis in a patient with metastatic renal cell carcinoma on a tyrosine kinase inhibitor. Anticancer Drugs. 2020 Dec 7 Epub 2020 Dec 07
    View PubMed
  3. Kusne YN, Kosiorek HE, Buras MR, Coppola KE, Verona PM, Cook CB, Karlin NJ. Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: A matched case-control study. Future Sci OA. 2020; FSO670.
  4. Yang J, Delara R, Magrina J, Magtibay P, Langstraat C, Dinh T, Karlin N, Vora SA, Butler K. Management and outcomes of primary vaginal Cancer. Gynecol Oncol. 2020 Nov; 159 (2):456-463 Epub 2020 Sept 22
    View PubMed
  5. Rice BJ, Buras MR, Kosiorek HE, Coppola KE, Amin SB, Verona PM, Cook CB, Karlin NJ. Survival and glycemic control in patients with coexisting lymphoma and diabetes: a case-control analysis. Future Sci OA. 2020 Oct 27; 7 (1):FSO641
    View PubMed
  6. Wiedmeier JE, Mountjoy LJ, Buras MR, Kosiorek HE, Coppola KE, Verona PM, Cook CB, Karlin NJ. Mortality and glycemic control among patients with acute and chronic myeloid leukemia and diabetes: a case-control study. Future Sci OA. 2020 Oct 26; 7 (1):FSO639
    View PubMed
  7. Karlin NJ, Buras MR, Kosiorek HE, Coppola KE, Verona PM, Cook CB. Assessing the relationship between institutional cancer and diabetes mortality rates using National Death Index data. Future Sci OA. 2020 Oct 20; 6 (10):FSO633
    View PubMed
  8. Bible KC, Menefee ME, Lin CC, Millward MJ, Maples WJ, Goh BC, Karlin NJ, Kane MA, Adkins DR, Molina JR, Donehower RC, Lim WT, Flynn PJ, Richardson RL, Traynor AM, Rubin J, LoRusso PM, Smallridge RC, Burton JK, Suman VJ, Kumar A, Voss JS, Rumilla KM, Kipp BR, Chintakuntlawar AV, Harris P, Erlichman C. An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer. Thyroid. 2020 Sep; 30 (9):1254-1262 Epub 2020 July 29
    View PubMed
  9. Iniguez-Ariza NM, Jasim S, Ryder MM, Chintakuntlawar AV, Morris JC, Hilger CR, Menefee ME, Smallridge RC, Karlin NJ, Alcaino C, Bible KC. Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy. J Clin Endocrinol Metab. 2020 Jul 1; 105 (7)
    View PubMed
  10. Chiang JS, Yu NY, Ertz-Archambault NM, Karlin NJ, Shoudis SN, Sio TT. Palliative radiotherapy for hepatobiliary obstruction caused by colorectal metastases. J Gastrointest Oncol. 2019 Dec; 10 (6):1157-1161
    View PubMed
  11. Yu NY, Ertz-Archambault NM, Karlin NJ, Shoudis SN, Sio TT. Palliative radiotherapy for hepatobiliary obstruction caused by colorectal metastases. Journal of Gastrointestinal Oncology. 2019; Accepted for Publication.
  12. Karlin NJ, Buras MR, Kosiorek HE, Verona PM, Cook CB. Glycemic control and survival of patients with coexisting diabetes mellitus and gastric or esophageal cancer. Future Sci OA. 2019 Jun 26; 5 (6):FSO397 Epub 2019 June 26
    View PubMed
  13. Karlin NJ, Mangold AR, Amin SB, Kosiorek HE, Buras MR, Verona PM, Cook CB. Survival and glycemic control in patients with coexisting melanoma and diabetes mellitus. Future Sci OA. 2019 Mar; 5 (3):FSO368 Epub 2019 Mar 07
    View PubMed
  14. Karlin NJ, Amin SB, Kosiorek HE, Buras MR, Verona PM, Cook CB. Survival and glycemic control in patients with colorectal cancer and diabetes mellitus. Future Sci OA. 2018 Oct; 4 (9):FSO335 Epub 2018 Aug 15
    View PubMed
  15. Taylor G, Karlin N, Halfdanarson TR, Coppola K, Grothey A. Leptomeningeal Carcinomatosis in Colorectal Cancer: The Mayo Clinic Experience. Clin Colorectal Cancer. 2018 Jun; 17 (2):e183-e187 Epub 2017 Nov 21
    View PubMed
  16. Gordon EJ, Parker D, Barth K, Pena J, Elvin JA, DeLeon T, Karlin NJ. Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer. Case Rep Oncol. 2018 May-Aug; 11 (2):399-403 Epub 2018 June 22
    View PubMed
  17. Karlin NJ, Amin SB, Kosiorek HE, Buras MR, Verona PM, Cook CB. Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus. Future Sci OA. 2018 Apr; 4 (4):FSO291 Epub 2018 Feb 21
    View PubMed
  18. Karlin NJ, Amin SB, Buras MR, Kosiorek HE, Verona PM, Cook CB. Patient outcomes from lung cancer and diabetes mellitus: a matched case-control study. Future Sci OA. 2018 Jan; 4 (1):FSO248 Epub 2017 Sept 26
    View PubMed
  19. Karlin NJ, Amin SB, Verona PM, Kosiorek HE, Cook CB. CO-EXISTING PROSTATE CANCER AND DIABETES MELLITUS: IMPLICATIONS FOR PATIENT OUTCOMES AND CARE. Endocr Pract. 2017 Jul; 23 (7):816-821 Epub 2017 May 23
    View PubMed
  20. Padrnos L, Karlin N, Halfdanarson TR. Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012. Rare Tumors. 2016 Nov 17; 8 (4):6804
    View PubMed
  21. Karlin NJ, Kosiorek HE, Castro JC, Cook CB. Risk of Hospitalization in Patients With Diabetes Mellitus Who Have Solid-Organ Malignancy Future Science OA.2016 Sept;2:(3):FSO129.
  22. Adike A, Karlin N, Menias C, Carey EJ. Pseudocirrhosis: A Case Series and Literature Review. Case Rep Gastroenterol. 2016 May-Aug; 10 (2):381-391 Epub 2016 July 29
    View PubMed
  23. Sakata KK, Gotway MB, Smith ML, Parish JM, Agrwal N, Karlin NJ, Swanson KL. Pulmonary Epithelioid Hemangioendothelioma Diagnosed With Endobronchial Biopsies: A Case Report and Literature Review. J Bronchology Interv Pulmonol. 2016 Apr; 23: (2)168-73.
    View PubMed
  24. Karlin NJ, Cheng M-R, Castro JC, Cook CB. Hyperglycemia among hospitalized cancer patients with coexisting diabetes mellitus. Diabetes Management.2015 Nov;5:(6):441-8.
  25. Jatoi A, Radecki Breitkopf C, Foster NR, Block MS, Grudem M, Wahner Hendrickson A, Carlson RE, Barrette B, Karlin N, Fields AP. A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients. Oncology. 2015; 88 (4):208-13 Epub 2014 Dec 06
    View PubMed
  26. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C, Endocrine Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, and the Mayo Phase 2 Consortium. A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H. J Clin Endocrinol Metab. 2014 May; 99 (5):1687-93 Epub 2014 Feb 25
    View PubMed
  27. Karlin NJ, Dueck AC, Nagi Reddy SK, Verona PM, Cook CB. Implications of breast cancer with diabetes mellitus on patient outcomes and care. Diabetes Management. 2014; 4(5):411-19.
  28. Vucicevic D, Carey EJ, Karlin NJ. Trastuzumab-induced hepatotoxicity: a case report. Breast Care (Basel). 2013 May; 8 (2):146-8
    View PubMed
  29. Karlin NJ, Dueck AC, Cook CB. Cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice. Endocr Pract. 2012 Nov-Dec; 18 (6):898-905
    View PubMed
  30. Bible KC, Suman VJ, Menefee ME, Smallridge RC, Molina JR, Maples WJ, Karlin NJ, Traynor AM, Kumar P, Goh BC, Lim WT, Bossou AR, Isham CR, Webster KP, Kukla AK, Bieber C, Burton JK, Harris P, Erlichman C, Mayo Phase 2 Consortium//Mayo Clinic Endocrine Malignances Disease Oriented Group. A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. J Clin Endocrinol Metab. 2012 Sep; 97 (9):3179-84 Epub 2012 July 06
    View PubMed
  31. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May 1; 18 (5):e162-7 Epub 2012 May 01
    View PubMed
  32. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8 (3 Suppl):e1s-5s
    View PubMed
  33. Geyer H, Karlin N, Palen B, Mesa R. Asian-variant intravascular lymphoma in the African race. Rare Tumors. 2012 Jan 2; 4 (1):e10 Epub 2012 Mar 19
    View PubMed
  34. Paripati HR, Karlin NJ, Schild SE, Vora SA, Dueck AC, Ross HJ. Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer-A retrospective analysis. Journal of Geriatric Oncology. 2012; 3(2):104-10.
  35. Kidd MT, Karlin NJ, Cook CB. Feminizing adrenal neoplasms: case presentations and review of the literature. J Clin Oncol. 2011 Feb 20; 29(6):e127-30. Epub 2010 Nov 29.
    View PubMed
  36. Vaidya R, Sood R, Karlin N, Jatoi A. Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Oncology. 2011; 81 (1):9-11 Epub 2011 Sept 02
    View PubMed
  37. Geyer HL, Viney J, Karlin N. Metastatic carcinoid presenting as a breast lesion. Curr Oncol. 2010 Nov; 17 (6):73-7
    View PubMed
  38. Geyer HL, Karlin N. Extraskeletal myxoid chondrosarcoma of the heart and review of current literature. Curr Oncol. 2010 Oct; 17(5):58-62.
    View PubMed
  39. Khan O, Tong WP, Karlin NJ. Metastatic lung adenocarcinoma in a 20-year-old patient. Curr Oncol. 2010 Feb; 17(1):56-8.
    View PubMed
  40. Wong NW, Wong WW, Karlin NJ, Gray RJ. Radiation recall secondary to adjuvant docetaxel after balloon-catheter based accelerated partial breast irradiation. Radiography. 2010; 16(3):253-5 Epub 2010 Apr 28.
  41. Kapetanakis V, Karlin NJ, McCullough AE, Magtibay PM. Primary ovarian malignant lymphoma presenting as ovarian carcinomatosis: a case report and literature review. Eur J Gynaecol Oncol. 2010; 31 (6):701-2
    View PubMed
  42. Thapaliya P, Karlin NJ. An update on inflammatory breast cancer. Oncology Reviews. 2009; 3(2):73-8.
  43. Barsky SH, Karlin NJ. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol. 2006 Mar; 3(3):138-51.
    View PubMed
  44. Barsky SH, Karlin NJ. Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia. 2005 Jul; 10(3):249-60.
    View PubMed
  45. Karlin NJ, Weintraub N, Chopra IJ. Current controversies in endocrinology: screening of asymptomatic elderly for subclinical hypothyroidism. J Am Med Dir Assoc. 2004 Sep-Oct; 5(5):333-6.
    View PubMed
  46. Hai C, Karlin N. Time-dependent uncoupling between myosin phosphorylation and contractile forces induced by Ca+2 depletion in smooth muscle. Archives Biochem & Biophysics. 1993 Mar; 301(2):299-304.
    View PubMed